Latest Renal artery Stories

KALAMAZOO, Mich., Oct. 9, 2012 /PRNewswire/ -- Ablative Solutions, Inc. (ASI), a privately-held company headquartered in Kalamazoo, MI with offices in Menlo Park, CA announced today that it was a recipient of Innovator of the Year award by Medical Main Street. Medical Main Street sponsors the Inno-vention 2012 conference, which brings together Michigan-based hospitals, research universities, pharmaceutical companies, medical device companies and researchers, with the goal of...

KALAMAZOO, Mich., June 19, 2012 /PRNewswire/ -- Ablative Solutions, Inc. (ASI), a privately-held company headquartered in Kalamazoo, MI with offices in Menlo Park, CA announced today that it has completed a Series A Preferred Stock financing, totaling approximately $5.3 million (including the conversion of the bridge financing completed earlier this year), to fund its unique technology platform. The round was led by BioStar Ventures and the Michigan Accelerator Fund, and included...

A new study from UCLA shows how magnetic resonance angiography (MRA) and computed tomography angiography (CTA) are equivalent in delineating anatomy in living renal donors. In a study that examined 30 patients and 60 kidneys, both modalities were "excellent" in detecting the number of renal arteries and veins. Dr. Mittul Gulati, lead author for the study noted, "either MRA or CTA are great tools for helping surgeons remove kidneys safely, identifying donor and recipient veins and vessels,...

LAGUNA HILLS, Calif., April 12, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology for the treatment of hypertension, announced today that veteran medical device sales and marketing executive Michael D. Gioffredi has been named Chief Commercialization Officer. Gioffredi has worked as an executive in the medical device industry for over 25 years and for the past six years served as Senior Vice President of...

LAGUNA HILLS, Calif., Feb. 13, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today that it will make its first detailed public presentation of preclinical data relating to its new V2 Renal Denervation System(TM) on Saturday, February 18, 2012 at the TRenD Workshop 2012, in Frankfurt, Germany. The presentation, titled "Percutaneous RF balloon-mediated renal denervation in under a minute: The...

ABBOTT PARK, Ill., Aug. 10, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the RX Herculink Elite® Renal Stent System for the treatment of renal artery stenosis (narrowing of the main arteries supplying blood to the kidneys) in patients with uncontrolled hypertension (high blood pressure). Over time, narrowed kidney arteries can lead to kidney failure and increased risk of heart disease, stroke and peripheral...

European trial explores treating renal artery blockages with a balloon expandable paclitaxel-eluting renal stent VANCOUVER, April 21 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula(TM) PTX(R) clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to...

Some invasive procedures that are becoming increasingly common as a first line of treatment for patients diagnosed with narrowed arteries in and around the kidneys may not be necessary, according to a new study by researchers at Wake Forest University Baptist Medical Center.The study shows that the condition, known as renal artery stenosis, only progresses to a dangerous blockage in a very small percentage of cases and does not always necessitate a surgical or even minimally-invasive...

By Yushkov, Yuriy Hoffman, Allison; Giudice, Anthony Background-Approximately one-third of organ donors in the United States are trauma victims. In general, kidneys with large subcapsular hematomas are not used for transplant because of the possibility of significant parenchymal injury. A large subcapsular renal hematoma may cause scarring resulting in renal parenchymal compression and development of the Page syndrome. Objective-To elucidate a successful method of evaluating kidneys subject...